The LSBio PathPlus™ Cancer series of antibodies include both well-established biomarkers of cancer (Cancer Pathology markers) as well as those that are used in asking a broader series of questions about the etiology, subclassification, and pathogenesis of cancer (Cancer Molecular markers). Cancer Molecular markers are those that are used by investigators in research laboratories who are studying novel biomarkers for genomic sub-classification of cancers, or identifying new markers to assist in diagnosis, prognosis, or monitoring for the recurrence of tumors. The Molecular markers also include those that are useful for studying mutation or translocations, cellular proliferation, the immune response to the tumor, apoptosis, or angiogenesis. This broad class of markers assists scientists who are investigating the etiology and pathogenesis of cancer.